Hamster Polyomavirus Research: Past, Present, and Future

Hamster polyomavirus (Mesocricetus auratus polyomavirus 1, HaPyV) was discovered as one of the first rodent polyomaviruses at the end of the 1960s in a colony of Syrian hamsters (<i>Mesocricetus auratus</i>) affected by skin tumors. Natural HaPyV infections have been recorded in Syrian h...

Full description

Bibliographic Details
Main Authors: Burkhard Jandrig, Hans Krause, Wolfgang Zimmermann, Emilija Vasiliunaite, Alma Gedvilaite, Rainer G. Ulrich
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/13/5/907
_version_ 1797534146255388672
author Burkhard Jandrig
Hans Krause
Wolfgang Zimmermann
Emilija Vasiliunaite
Alma Gedvilaite
Rainer G. Ulrich
author_facet Burkhard Jandrig
Hans Krause
Wolfgang Zimmermann
Emilija Vasiliunaite
Alma Gedvilaite
Rainer G. Ulrich
author_sort Burkhard Jandrig
collection DOAJ
description Hamster polyomavirus (Mesocricetus auratus polyomavirus 1, HaPyV) was discovered as one of the first rodent polyomaviruses at the end of the 1960s in a colony of Syrian hamsters (<i>Mesocricetus auratus</i>) affected by skin tumors. Natural HaPyV infections have been recorded in Syrian hamster colonies due to the occurrence of skin tumors and lymphomas. HaPyV infections of Syrian hamsters represent an important and pioneering tumor model. Experimental infections of Syrian hamsters of different colonies are still serving as model systems (e.g., mesothelioma). The observed phylogenetic relationship of HaPyV to murine polyomaviruses within the genus <i>Alphapolyomavirus,</i> and the exclusive detection of other cricetid polyomaviruses, i.e., common vole (Microtus arvalis polyomavirus 1) and bank vole (Myodes glareolus polyomavirus 1) polyomaviruses, in the genus <i>Betapolyomavirus</i>, must be considered with caution, as knowledge of rodent-associated polyomaviruses is still limited. The genome of HaPyV shows the typical organization of polyomaviruses with an early and a late transcriptional region. The early region encodes three tumor (T) antigens including a middle T antigen; the late region encodes three capsid proteins. The major capsid protein VP1 of HaPyV was established as a carrier for the generation of autologous, chimeric, and mosaic virus-like particles (VLPs) with a broad range of applications, e.g., for the production of epitope-specific antibodies. Autologous VLPs have been applied for entry and maturation studies of dendritic cells. The generation of chimeric and mosaic VLPs indicated the high flexibility of the VP1 carrier protein for the insertion of foreign sequences. The generation of pseudotype VLPs of original VP1 and VP2–foreign protein fusion can further enhance the applicability of this system. Future investigations should evaluate the evolutionary origin of HaPyV, monitor its occurrence in wildlife and Syrian hamster breeding, and prove its value for the generation of potential vaccine candidates and as a gene therapy vehicle.
first_indexed 2024-03-10T11:25:29Z
format Article
id doaj.art-1319f91824694ee0a7b423eee0b92c18
institution Directory Open Access Journal
issn 1999-4915
language English
last_indexed 2024-03-10T11:25:29Z
publishDate 2021-05-01
publisher MDPI AG
record_format Article
series Viruses
spelling doaj.art-1319f91824694ee0a7b423eee0b92c182023-11-21T19:39:03ZengMDPI AGViruses1999-49152021-05-0113590710.3390/v13050907Hamster Polyomavirus Research: Past, Present, and FutureBurkhard Jandrig0Hans Krause1Wolfgang Zimmermann2Emilija Vasiliunaite3Alma Gedvilaite4Rainer G. Ulrich5Department of Urology, University Medical Center Magdeburg, Leipziger Str. 44, 39120 Magdeburg, GermanyCharité—Universitätsmedizin Berlin, Urologische Klinik, Charitéplatz 1, 10117 Berlin, GermanyLGC Genomics, BU Sequencing, Ostendstr. 25, 12459 Berlin, GermanyInstitute of Biotechnology, Life Sciences Center, Vilnius University, Saulėtekio al. 7, LT-10257 Vilnius, LithuaniaInstitute of Biotechnology, Life Sciences Center, Vilnius University, Saulėtekio al. 7, LT-10257 Vilnius, LithuaniaInstitute of Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Südufer 10, 17493 Greifswald-Insel Riems, GermanyHamster polyomavirus (Mesocricetus auratus polyomavirus 1, HaPyV) was discovered as one of the first rodent polyomaviruses at the end of the 1960s in a colony of Syrian hamsters (<i>Mesocricetus auratus</i>) affected by skin tumors. Natural HaPyV infections have been recorded in Syrian hamster colonies due to the occurrence of skin tumors and lymphomas. HaPyV infections of Syrian hamsters represent an important and pioneering tumor model. Experimental infections of Syrian hamsters of different colonies are still serving as model systems (e.g., mesothelioma). The observed phylogenetic relationship of HaPyV to murine polyomaviruses within the genus <i>Alphapolyomavirus,</i> and the exclusive detection of other cricetid polyomaviruses, i.e., common vole (Microtus arvalis polyomavirus 1) and bank vole (Myodes glareolus polyomavirus 1) polyomaviruses, in the genus <i>Betapolyomavirus</i>, must be considered with caution, as knowledge of rodent-associated polyomaviruses is still limited. The genome of HaPyV shows the typical organization of polyomaviruses with an early and a late transcriptional region. The early region encodes three tumor (T) antigens including a middle T antigen; the late region encodes three capsid proteins. The major capsid protein VP1 of HaPyV was established as a carrier for the generation of autologous, chimeric, and mosaic virus-like particles (VLPs) with a broad range of applications, e.g., for the production of epitope-specific antibodies. Autologous VLPs have been applied for entry and maturation studies of dendritic cells. The generation of chimeric and mosaic VLPs indicated the high flexibility of the VP1 carrier protein for the insertion of foreign sequences. The generation of pseudotype VLPs of original VP1 and VP2–foreign protein fusion can further enhance the applicability of this system. Future investigations should evaluate the evolutionary origin of HaPyV, monitor its occurrence in wildlife and Syrian hamster breeding, and prove its value for the generation of potential vaccine candidates and as a gene therapy vehicle.https://www.mdpi.com/1999-4915/13/5/907rodent polyomavirusesvirus discoverySyrian hamstergenome organizationmiddle T antigentumor model
spellingShingle Burkhard Jandrig
Hans Krause
Wolfgang Zimmermann
Emilija Vasiliunaite
Alma Gedvilaite
Rainer G. Ulrich
Hamster Polyomavirus Research: Past, Present, and Future
Viruses
rodent polyomaviruses
virus discovery
Syrian hamster
genome organization
middle T antigen
tumor model
title Hamster Polyomavirus Research: Past, Present, and Future
title_full Hamster Polyomavirus Research: Past, Present, and Future
title_fullStr Hamster Polyomavirus Research: Past, Present, and Future
title_full_unstemmed Hamster Polyomavirus Research: Past, Present, and Future
title_short Hamster Polyomavirus Research: Past, Present, and Future
title_sort hamster polyomavirus research past present and future
topic rodent polyomaviruses
virus discovery
Syrian hamster
genome organization
middle T antigen
tumor model
url https://www.mdpi.com/1999-4915/13/5/907
work_keys_str_mv AT burkhardjandrig hamsterpolyomavirusresearchpastpresentandfuture
AT hanskrause hamsterpolyomavirusresearchpastpresentandfuture
AT wolfgangzimmermann hamsterpolyomavirusresearchpastpresentandfuture
AT emilijavasiliunaite hamsterpolyomavirusresearchpastpresentandfuture
AT almagedvilaite hamsterpolyomavirusresearchpastpresentandfuture
AT rainergulrich hamsterpolyomavirusresearchpastpresentandfuture